Medicine and Dentistry
Diseases
100%
Neoplasm
71%
Malignant Neoplasm
42%
Magnetic Resonance Imaging
36%
Systematic Review
33%
Breast Cancer
32%
Clinical Trial
29%
Congestive Heart Failure
25%
Overall Survival
24%
Meta-Analysis
24%
Recurrent Disease
23%
Cancer
22%
Infection
22%
Prevalence
22%
Odds Ratio
22%
Hazard Ratio
21%
Biological Marker
21%
Prostate Cancer
21%
Biopsy Technique
19%
Clinician
19%
Radiation Therapy
19%
Computer Assisted Tomography
19%
Apoplexy
18%
Quality of Life
18%
Lung
18%
Cardiovascular System
17%
Metastatic Carcinoma
16%
Multiple Myeloma
16%
Surgeon
16%
Health Care Cost
16%
Pediatrics
15%
Disease
15%
Bleeding
15%
Adverse Event
14%
Cohort Analysis
14%
Oncology
14%
Body Mass Index
13%
Atrial Fibrillation
13%
Diabetes
13%
Coronary Artery Disease
13%
Placebo
13%
Cardiovascular Disease
13%
In Vitro
13%
Cohort Effect
12%
Liver Transplantation
12%
COVID-19
12%
Hemodynamic
12%
Aneurysm
12%
Alzheimer's Disease
11%
Colorectal Carcinoma
11%
Randomized Controlled Trial
11%
Arm
11%
Epileptic Seizure
10%
Combination Therapy
10%
Echocardiography
10%
Myocardial Infarction
10%
Comorbidity
10%
Ovarian Cancer
10%
T Cell
10%
Pathophysiology
9%
Amyloid Protein
9%
Medicine
9%
Diabetes Mellitus
9%
Progression Free Survival
9%
Health Care
9%
Risk Stratification
8%
Pancreas Cancer
8%
Lung Cancer
8%
Revascularization
8%
Hepatocellular Carcinoma
8%
Atherosclerosis
8%
Clinical Feature
8%
Fibrosis
8%
Polycystic Kidney Disease
8%
Ejection Fraction
8%
Cancer Therapy
8%
Neuropathy
8%
Logistic Regression Analysis
8%
Kidney Function
8%
Allograft
7%
Receptor
7%
Percutaneous Coronary Intervention
7%
Gene Expression
7%
Positron Emission Tomography
7%
Emergency Department
7%
Patient Care
7%
Surgical Technique
7%
Amyloidosis
7%
Medical Record
7%
Blood Pressure
7%
Liver Disease
7%
Melanoma
7%
Patient Referral
7%
Primary Health Care
7%
Brain Ischemia
7%
Morphology
7%
Cancer Risk
7%
Stenosis
7%
Reoperation
7%
Ganglioglioma
7%
Keyphrases
Confidence Interval
57%
Tumor
44%
Meta-analysis
31%
Mayo Clinic
31%
Risk Factors
28%
Clinical Trials
28%
Odds Ratio
27%
Clinical Outcomes
25%
Magnetic Resonance Imaging
25%
Hazard Ratio
25%
Overall Survival
24%
United States
23%
Alzheimer's Disease
21%
High Risk
21%
Systematic Meta-analysis
21%
Breast Cancer
19%
Multiple Myeloma
18%
Chemotherapy
18%
Prostate Cancer
17%
Minnesota
17%
T Cells
16%
Heart Failure
16%
Computed Tomography
16%
Placebo
15%
Obesity
15%
Liver
14%
Quality of Life
14%
Population-based Study
14%
Atrial Fibrillation
14%
Body Mass Index
14%
Clinical Features
14%
Colorectal Cancer
13%
Rheumatoid Arthritis
13%
Clinical Practice
13%
Gene Expression
13%
Older Adults
13%
Liver Transplantation
13%
Hypertension
13%
Randomized Controlled Trial
13%
Lung
12%
Kidney
12%
Aging
12%
Diabetes
11%
Inflammation
11%
Pathophysiology
11%
Olmsted County
11%
Multiple Sclerosis
11%
Etiology
11%
Cardiovascular Disease
11%
Adverse Events
11%
In Cancer
11%
Resection
11%
Phase II Trial
10%
COVID-19
10%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
10%
Type 1 Diabetes Mellitus (T1DM)
10%
Randomized Trial
10%
Coronary Artery Disease
10%
Rochester
10%
Myocardial Infarction
10%
Pancreatic Cancer
10%
Comorbidity
10%
Single nucleotide Polymorphism
10%
Transplantation
10%
Epidemiology
10%
Malignancy
9%
Surgeons
9%
Progression-free Survival
9%
Hospitalization
9%
Disease Progression
9%
Chronic Lymphocytic Leukemia
9%
Apoptosis
9%
Radiation Therapy
9%
Clinical Application
9%
Natural History
9%
Type 2 Diabetes Mellitus (T2DM)
9%
Genome-wide Association Study
9%
Seizure
9%
Growth Factors
9%
Immune Response
9%
Hepatocellular Carcinoma
9%
Clinically Significant
9%
Non-associated
9%
Inflammatory Bowel Disease
9%
Clinical Presentation
8%
Ovarian Cancer
8%
No Significant Difference
8%
Acute Myocardial Infarction
8%
Treatment Options
8%
Blood Pressure
8%
Dementia
8%
Patient Management
8%
Randomized Clinical Trial
8%
Mild Cognitive Impairment
8%
Clinical Characteristics
8%
Insulin
8%
Risk Stratification
8%
Crohn's Disease
8%
Genotype
8%
Cancer Treatment
8%